FRFernando L. Riccillo

Fernando L. Riccillo

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Fernando L. Riccillo has a total of 8 co-authors. Here are the top co-authors by number of shared publications:

  • Kevin I. Martínez

    Department of Citology, Histology and Embriology, School of Medical Sciences, National University of La Plata, La Plata, Argentina; National Scientific and Technical Research Council (CONICET), Argentina

    2 shared publications
  • Marcela N. García

    Department of Citology, Histology and Embriology, School of Medical Sciences, National University of La Plata, La Plata, Argentina

    2 shared publications
  • Edgardo D. Carosella

    Atomic Energy and Alternative Energies Agency (CEA), Hematology and Immunology Research Division, Saint-Louis Hospital, Paris, France; U976 HIPI Unit, University of Paris, Paris, France

    1 shared publication
  • Edgardo D. Carosella

    Saint-Louis Hospital 1 Hemato-Immunology Research Department, CEA, DRF-Francois Jacob Institute Paris, France

    1 shared publication
  • Fernando J. Sepúlveda

    Department of Biochemistry and Molecular Biology, Faculty of Biological Sciences, University of Concepción, Concepción, Chile; Exercise and Rehabilitation, Sciences Institute School of Speech Therapy of Rehabilitation Sciences, Universidad Andres Bello, Santiago, 7591538, Chile

    1 shared publication
  • Fernando J. Sepúlveda

    1 shared publication

Latest Publications

  • Cannabidiol modulates classical and non-classical HLA expression in human choriocarcinoma cell line

    by Kevin I. Martínez, María B. Palma, Fernando J. Sepúlveda, Edgardo D. Carosella, Marcela N. García, Fernando L. Riccillo

  • Open Access

    CANNABIDIOL MODULATES CLASSICAL AND NON-CLASSICAL HLA EXPRESSION IN HUMAN CHORIOCARCINOMA CELL LINE

    by Kevin I. Martínez, María B. Palma, Fernando J. Sepúlveda, Edgardo D. Carosella, Marcela N. García, Fernando L. Riccillo

    Cannabidiol (CBD) modulates diverse signaling pathways with potential relevance to tumor immune escape, however its impact on the regulation of classical and non-classical HLA class I molecules remains incompletely understood. Here, we examined the mechanisms by which CBD regulates HLA expression in JEG-3 choriocarcinoma cells, focusing on cannabinoid-related receptors and intracellular Ca²⁺ signaling. CBD increased the expression of classical HLA class I genes—most notably HLA-C—while reducing HLA-G levels, a non-classical HLA class I molecule that acts as a local immunosuppressor. Receptor profiling revealed constitutive expression of CB1 and CB2, whereas GPR55 and PPARγ expression became detectable only after CBD exposure. Functional inhibition assays showed that HLA-G downregulation was selectively attenuated by CB1 blockade, with no meaningful contribution from CB2 or GPR55. In contrast, CBD-induced HLA-C upregulation required GPR55 and CB2 activity, while being unaffected by CB1 inhibition, indicating distinct receptor pathways for classical and non-classical HLA regulation. Calcium chelation using BAPTA further demonstrated that HLA-G modulation is highly sensitive to intracellular Ca²⁺ reduction, whereas classical HLA expression required higher BAPTA concentrations to be affected. Altogether, these findings identify CBD as a dual immunomodulatory agent capable of enhancing tumor immune visibility while limiting immunotolerant HLA-G expression through receptor-specific and Ca²⁺-dependent mechanisms.